Evidence map›Paper›PMID 33094116›Full record

ArticleOpen forum infectious diseases2020

Powassan Virus Neuropathology and Genomic Diversity in Patients With Fatal Encephalitis.

Erica Normandin, Isaac H Solomon, Siavash Zamirpour, Jacob Lemieux, Catherine A Freije, Shibani S Mukerji, Christopher Tomkins-Tinch, Daniel Park, Pardis C Sabeti, Anne Piantadosi

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Features of Consistent Powassan Virus Lineage II Focus in Southern Maine, United States.The American journal of tropical medicine and hygiene · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Eastern Equine Encephalitis Virus Diversity in Massachusetts Patients, 1938-2020.The American journal of tropical medicine and hygiene · 2023
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Erica NormandinBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Isaac H SolomonDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Siavash ZamirpourBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Jacob LemieuxBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Catherine A FreijeBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Shibani S MukerjiDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Christopher Tomkins-TinchBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Daniel ParkBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Pardis C SabetiBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Anne PiantadosiBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0002-5942-1534
Broad Institute · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Harvard Systems Biology Graduate ProgramT32GM080177 · NIGMS · HARVARD UNIVERSITY · PI MITCHISON, TIMOTHY J, MURRAY, ANDREW W · 2010 to 2019
$2.8M
Emergence of tick borne encephalitis in North AmericaR01AI137424 · NIAID · TUFTS UNIVERSITY BOSTON · PI EBEL, GREGORY DAVID, TELFORD, SAM R · 2019 to 2023
$2.5M
Clinical and viral genomic approaches to evaluate the emergence of Powassan virusK08AI139348 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI PIANTADOSI, ANNE L · 2019 to 2022
$752k
NIAID NIH HHS K08 AI139348NIAID NIH HHS R01 AI137424NIAID NIH HHS T32 AI007061NIGMS NIH HHS T32 GM080177
6 · The paper itself

Abstract

backgroundPowassan virus (POWV) is an emerging cause of severe encephalitis; very little is known about human pathogenicity due to challenges in diagnosis and viral RNA recovery. We present 3 patients with fatal encephalitis due to POWV lineage II (deer tick virus).

methodsWe obtained 27 unique samples, including from brain biopsy and autopsy, and used metagenomic sequencing, quantitative reverse transcriptase polymerase chain reaction, and a newly developed CRISPR-based diagnostic assay to perform the first detailed characterization of POWV compartmentalization and genomics between and within human subjects.

resultsIn all 3 patients, imaging and histopathology findings were notable for profound cerebellar involvement. All patients were initially diagnosed with POWV by metagenomic sequencing, and 2 of the 3 had negative clinical testing by serology. We detected POWV RNA in 13 clinical samples; levels were highest in the cerebellum, and there was very little involvement of peripheral tissue. We assembled complete POWV genomes from 8 samples, providing unique information about the strains of POWV lineage II (deer tick virus) that infect humans.

conclusionsWe demonstrate the utility of molecular assays for detecting POWV infection, including in seronegative patients, and nominate viral genomic features that may relate to human infection and neuropathogenicity. The cerebellum was identified as a key target POWV in fatal infection, by radiological and histopathological findings as well as molecular testing.

Indexed as

flavivirusmolecular diagnosticsneuropathologyviral genomics

Identifiers

PMID33094116
PMCPMC7566439
OpenAlexW3081732002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.